Pharmacologic effects on coronary microvessels during myocardial ischaemia.
Tillmanns
H
H
Abteilung Inn. Med./Kardiologie, University of Giessen, West Germany.
Neumann
F J
FJ
Parekh
N
N
Dorigo
O
O
Tiefenbacher
C
C
Zimmermann
R
R
Steinhausen
M
M
Kübler
W
W
D000818:Animals; D001783:Blood Flow Velocity; D002199:Capillary Permeability; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology*; D003331:Coronary Vessels / Q000187:drug effects*; D004906:Erythrocyte Count; D005227:Fatty Acids / Q000378:metabolism; D005711:Gallopamil / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology*; D007213:Indomethacin / Q000494:pharmacology*; D008833:Microcirculation / Q000187:drug effects; D010976:Platelet Count / Q000187:drug effects; D051381:Rats; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors; D014700:Verapamil / Q000494:pharmacology*
D005227:Fatty Acids; D007093:Imidazoles; C029166:dazoxiben; D005711:Gallopamil; D014700:Verapamil; D013930:Thromboxane-A Synthase; D007213:Indomethacin